A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland

Herantis Pharma awarded Innovation prize of the Chemical Industry Federation of Finland Herantis Pharma Plc Press release 19 Apr 2018…

Read More

Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema

Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema Herantis Pharma Plc Company release 16 Apr 2018…

Read More

Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders

Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders Herantis Pharma Plc Company release 11 April 2018 at 5:00…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.